✦ LIBER ✦

EVALUATION OF QUALITY OF LIFE, SIDE EFFECTS AND DURATION OF THERAPY IN A PHASE 3 STUDY OF INTERMMITTENT MONOTHERAPY VERSUS CONTINOUS COMBINED ANDROGEN DEPRIVATION

✍ Scribed by Da Silva, Fernando Calais; Goncalves, Frederico; Santos, Americo; Kliment, Jan; Whelan, Peter; Oliver, Tim; Antoniou, Nikos; Pastidis, Sypros; Robertson, Chris

Book ID: 122854160
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 184 KB
Volume: 179
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(08)60727-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EVALUATION OF QUALITY OF LIFE, SIDE EFFE

EVALUATION OF QUALITY OF LIFE, SIDE EFFECTS AND DURATION OF THERAPY IN A PHASE 3 STUDY OF INTERMITTENT MONOTHERAPY VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION

✍ F.E. Calais Da Silva; F. Goncalves; A. Santos; J. Kliment; F.M. Calais Da Silva; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

972 Effects of prior use of statins in a

972 Effects of prior use of statins in a phase 3 study of intermittent versus continuous combined androgen deprivation

✍ Calais Da Silva, F.; Calais Da Silva, F.; Gonçalves, F.; Kliment, J.; Whelan, P. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 200 KB

PD27-10 EFFECTS OF PRIOR USE OF STATINS

PD27-10 EFFECTS OF PRIOR USE OF STATINS IN A PHASE 3 STUDY OF INTERMITTENT VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION

✍ da silva Junior, Fernando calais; da Silva, Fernando Calais; Gonçalves, Frederic 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

Evaluating health-related quality-of-lif

Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer

✍ Carol M. Moinpour, Gary W. Donaldson, Astra M. Liepa, Allen S. Melemed, Joyce O’ 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 392 KB

The added value of the combined evaluati

The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study. Results of an EORTC — NCIC — SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)

✍ Therasse, P.; Mauriac, L.; Welnicka, M.; Bruning, P.; Cufer, T.; Lichinitser, R. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 132 KB